Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

230 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
STAT3 and cardiac remodeling.
Haghikia A, Stapel B, Hoch M, Hilfiker-Kleiner D. Haghikia A, et al. Heart Fail Rev. 2011 Jan;16(1):35-47. doi: 10.1007/s10741-010-9170-x. Heart Fail Rev. 2011. PMID: 20407820 Review.
Continuous glycoprotein-130-mediated signal transducer and activator of transcription-3 activation promotes inflammation, left ventricular rupture, and adverse outcome in subacute myocardial infarction.
Hilfiker-Kleiner D, Shukla P, Klein G, Schaefer A, Stapel B, Hoch M, Müller W, Scherr M, Theilmeier G, Ernst M, Hilfiker A, Drexler H. Hilfiker-Kleiner D, et al. Circulation. 2010 Jul 13;122(2):145-55. doi: 10.1161/CIRCULATIONAHA.109.933127. Epub 2010 Jun 28. Circulation. 2010. PMID: 20585009
Signal transducer and activator of transcription 3-mediated regulation of miR-199a-5p links cardiomyocyte and endothelial cell function in the heart: a key role for ubiquitin-conjugating enzymes.
Haghikia A, Missol-Kolka E, Tsikas D, Venturini L, Brundiers S, Castoldi M, Muckenthaler MU, Eder M, Stapel B, Thum T, Haghikia A, Petrasch-Parwez E, Drexler H, Hilfiker-Kleiner D, Scherr M. Haghikia A, et al. Eur Heart J. 2011 May;32(10):1287-97. doi: 10.1093/eurheartj/ehq369. Epub 2010 Oct 21. Eur Heart J. 2011. PMID: 20965886
Erythropoietin preserves the endothelial differentiation capacity of cardiac progenitor cells and reduces heart failure during anticancer therapies.
Hoch M, Fischer P, Stapel B, Missol-Kolka E, Sekkali B, Scherr M, Favret F, Braun T, Eder M, Schuster-Gossler K, Gossler A, Hilfiker A, Balligand JL, Drexler H, Hilfiker-Kleiner D. Hoch M, et al. Cell Stem Cell. 2011 Aug 5;9(2):131-43. doi: 10.1016/j.stem.2011.07.001. Cell Stem Cell. 2011. PMID: 21816364 Free article.
MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy.
Halkein J, Tabruyn SP, Ricke-Hoch M, Haghikia A, Nguyen NQ, Scherr M, Castermans K, Malvaux L, Lambert V, Thiry M, Sliwa K, Noel A, Martial JA, Hilfiker-Kleiner D, Struman I. Halkein J, et al. J Clin Invest. 2013 May;123(5):2143-54. doi: 10.1172/JCI64365. Epub 2013 Apr 24. J Clin Invest. 2013. PMID: 23619365 Free PMC article.
Phenotyping and outcome on contemporary management in a German cohort of patients with peripartum cardiomyopathy.
Haghikia A, Podewski E, Libhaber E, Labidi S, Fischer D, Roentgen P, Tsikas D, Jordan J, Lichtinghagen R, von Kaisenberg CS, Struman I, Bovy N, Sliwa K, Bauersachs J, Hilfiker-Kleiner D. Haghikia A, et al. Basic Res Cardiol. 2013 Jul;108(4):366. doi: 10.1007/s00395-013-0366-9. Epub 2013 Jun 28. Basic Res Cardiol. 2013. PMID: 23812247 Free PMC article.
230 results